SPRO
Spero Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.13
+0.89%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.17
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +111.7%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.17 | -$0.16 | Beat 5.88% | — |
| May 13, 2026 | -$0.18 | -$0.13 | Beat 27.78% | $258.0K |
| Mar 26, 2026 | -$0.20 | $0.53 | Beat 365.00% | $41.3M |
| Nov 13, 2025 | -$0.25 | -$0.13 | Beat 48.00% | $3.0M |
| Mar 27, 2025 | -$0.35 | -$0.38 | Miss -8.57% | $9.4M |
| Nov 14, 2024 | -$0.27 | -$0.32 | Miss -18.52% | $13.5M |
| May 15, 2024 | -$0.07 | -$0.24 | Miss -242.86% | $4.2M |
| Mar 13, 2024 | -$0.10 | $0.96 | Beat 1060.00% | $71.8M |
| Nov 13, 2023 | -$0.15 | $0.02 | Beat 113.33% | $25.5M |
| Aug 10, 2023 | -$0.29 | -$0.23 | Beat 20.69% | $788.0K |
| May 11, 2023 | -$0.35 | -$0.25 | Beat 28.57% | $740.0K |
| Nov 14, 2022 | -$0.34 | -$0.33 | Beat 2.94% | $1.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026